2020
DOI: 10.1097/md.0000000000020714
|View full text |Cite
|
Sign up to set email alerts
|

Propofol-based total intravenous anesthesia improves survival compared to desflurane anesthesia in gastric cancer surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
28
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 23 publications
(45 citation statements)
references
References 36 publications
2
28
2
Order By: Relevance
“…A significant finding in the present study is that propofol anesthesia in GBM surgery is associated with better survival and a lower risk of postoperative recurrence than desflurane anesthesia. The result is consistent with our previous studies in which propofol anesthesia demonstrated better survival than desflurane anesthesia following cancer surgeries (intrahepatic cholangiocarcinoma, hepatocellular carcinoma, pancreatic cancer, gastric cancer, prostate cancer, and colon cancer) [ 18 23 ]. However, Sessler et al [ 27 ] conducted a randomized controlled trial (RCT) among 2,108 women at 13 hospitals in Argentina, Austria, China, Germany, Ireland, New Zealand, Singapore, and the USA.…”
Section: Discussionsupporting
confidence: 92%
See 3 more Smart Citations
“…A significant finding in the present study is that propofol anesthesia in GBM surgery is associated with better survival and a lower risk of postoperative recurrence than desflurane anesthesia. The result is consistent with our previous studies in which propofol anesthesia demonstrated better survival than desflurane anesthesia following cancer surgeries (intrahepatic cholangiocarcinoma, hepatocellular carcinoma, pancreatic cancer, gastric cancer, prostate cancer, and colon cancer) [ 18 23 ]. However, Sessler et al [ 27 ] conducted a randomized controlled trial (RCT) among 2,108 women at 13 hospitals in Argentina, Austria, China, Germany, Ireland, New Zealand, Singapore, and the USA.…”
Section: Discussionsupporting
confidence: 92%
“…As our previous reports [ 18 23 ], in brief, propofol anesthesia was maintained at an effect-site concentration (Ce) of 3.0–4.0 μg/mL by a target-controlled infusion (TCI) system (Fresenius Orchestra Primea; Fresenius Kabi AG, Bad Homburg, Germany); desflurane vaporizer was maintained between 4% and 10% (target minimum alveolar concentration of 0.7–1.3) [ 24 ]. During maintenance of anesthesia, all patients received FiO 2 of 100% oxygen at a flow rate of 300 mL/min in a closed breathing system, and desflurane or Ce of propofol was adjusted downward and upward by 0.5–2% or Ce 0.2–0.5 μg/mL, respectively, if needed based on hemodynamics.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…More similar studies have been published, some with overall survival at different time points as the main outcome, some studying the duration of recurrence free survival [ 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 ]. The number of included patients in studies with results that do not support the hypothesis [ 33 , 37 , 38 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 ] and studies supporting it [ 34 , 35 , 36 , 39 , 40 , 41 , 51 , 52 , 53 , 54 , 55 , 56 ], are quite equal. If anything, there are more patients in studies without support for the hypothesis.…”
Section: Retrospective Patient Studiesmentioning
confidence: 99%